These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 30595183

  • 1. Myocardial Partition Coefficient of Gadolinium: A Pilot Study in Patients With Acute Myocarditis, Chronic Myocardial Infarction, and in Healthy Volunteers.
    Teixeira T, Hafyane T, Jerosch-Herold M, Marcotte F, Mongeon FP.
    Can J Cardiol; 2019 Jan; 35(1):51-60. PubMed ID: 30595183
    [Abstract] [Full Text] [Related]

  • 2. Myocardial edema in acute myocarditis: relationship of T2 relaxometry and late enhancement burden by using dual-contrast turbo spin-echo MRI.
    Mayr A, Klug G, Feistritzer HJ, Reinstadler SJ, Reindl M, Esterhammer R, Feuchtner G, Metzler B, Schocke MF.
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1789-1794. PubMed ID: 28528429
    [Abstract] [Full Text] [Related]

  • 3. Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA.
    Doltra A, Skorin A, Hamdan A, Schnackenburg B, Gebker R, Klein C, Nagel E, Fleck E, Kelle S.
    Eur Radiol; 2014 Sep; 24(9):2192-200. PubMed ID: 24828537
    [Abstract] [Full Text] [Related]

  • 4. Gadolinium chelate kinetics in cardiac MR imaging of myocarditis: comparison to acute myocardial infarction and impact on late gadolinium enhancement.
    Jacquier A, Prost C, Amabile N, Giorgi R, Flavian A, Gaubert JY, Varoquaux A, Paganelli F, Bartoli JM, Moulin G.
    Invest Radiol; 2011 Nov; 46(11):705-10. PubMed ID: 21808201
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.
    Ammirati E, Moroni F, Sormani P, Peritore A, Milazzo A, Quattrocchi G, Cipriani M, Oliva F, Giannattasio C, Frigerio M, Roghi A, Camici PG, Pedrotti P.
    Int J Cardiol; 2017 Mar 15; 231():216-221. PubMed ID: 27913009
    [Abstract] [Full Text] [Related]

  • 9. Early myocardial gadolinium enhancement in patients with myocarditis: Validation of "Lake Louise consensus" criteria using a single bolus of 0.1mmol/Kg of a high relaxivity gadolinium-based contrast agent.
    Galea N, Francone M, Fiorelli A, Noce V, Giannetta E, Chimenti C, Frustaci A, Catalano C, Carbone I.
    Eur J Radiol; 2017 Oct 15; 95():89-95. PubMed ID: 28987703
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.
    Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S.
    J Cardiovasc Magn Reson; 2014 May 23; 16(1):36. PubMed ID: 24886708
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ultra low-dose of gadobenate dimeglumine for late gadolinium enhancement (LGE) imaging in acute myocardial infarction: a feasibility study.
    Galea N, Francone M, Zaccagna F, Ciolina F, Cannata D, Algeri E, Agati L, Catalano C, Carbone I.
    Eur J Radiol; 2014 Dec 23; 83(12):2151-2158. PubMed ID: 25293818
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and Prognostic Impact of Septal Late Gadolinium Enhancement in Acute Myocarditis With or Without Preserved Left Ventricular Function.
    Imazio M, Angelico G, Andriani M, Lobetti-Bodoni L, Davini O, Giustetto C, Rinaldi M.
    Am J Cardiol; 2018 Dec 01; 122(11):1955-1958. PubMed ID: 30266253
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction.
    Dall'Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM, Cuculi F, Kharbanda RK, Banning AP, Choudhury RP, Karamitsos TD, Neubauer S.
    J Cardiovasc Magn Reson; 2012 Feb 06; 14(1):15. PubMed ID: 22309452
    [Abstract] [Full Text] [Related]

  • 17. Assessment of myocardial injury after reperfused infarction by T1ρ cardiovascular magnetic resonance.
    Stoffers RH, Madden M, Shahid M, Contijoch F, Solomon J, Pilla JJ, Gorman JH, Gorman RC, Witschey WRT.
    J Cardiovasc Magn Reson; 2017 Feb 15; 19(1):17. PubMed ID: 28196494
    [Abstract] [Full Text] [Related]

  • 18. MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study.
    Bandettini WP, Kellman P, Mancini C, Booker OJ, Vasu S, Leung SW, Wilson JR, Shanbhag SM, Chen MY, Arai AE.
    J Cardiovasc Magn Reson; 2012 Nov 30; 14(1):83. PubMed ID: 23199362
    [Abstract] [Full Text] [Related]

  • 19. Impact of myocardial scars on left ventricular deformation in type 2 diabetes mellitus after myocardial infarction by contrast-enhanced cardiac magnetic resonance.
    Gao Y, Xu HY, Guo YK, Wen XL, Shi R, Li Y, Yang ZG.
    Cardiovasc Diabetol; 2021 Oct 25; 20(1):215. PubMed ID: 34696783
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.